Paul Steckler

Biography

 Paul is a commercial leader with more than 17 years of Pharmaceutical experience across a broad range of therapeutic areas. Paul gained a BSc in Microbiology & Virology from Warwick University before joining the pharmaceutical industry in 1997. Paul spent the majority of his career at Pfizer working across multiple therapy areas including Genotropin, Somavert, Zyvoz, Vfend, Ecalta, Rapamune and Tygacil. Paul successfully reinvigorated the specialty portfolio returning the brands to growth in excess of 14%. Since leaving Pfizer in 2012 Paul has worked with a number of smaller pharmaceutical companies with a focus on specialty medications including launching Jinarc (in polycystic kidney disease) for Otsuka Pharmaceuticals. All of this experience is utilised to ensure commercial plans are fit for purpose and focused on achieving the best return for current and future assets.

Research Interest

 Pharmaceutics